Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly

Published:2017-09-05 Issue:12 Volume:17 Page:3219-3227
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Vincenti F.¹,Blancho G.²,Durrbach A.³,Grannas G.⁴,Grinyó J.⁵,Meier-Kriesche H.-U.⁶,Polinsky M.⁶,Yang L.⁶,Larsen C. P.⁷

Affiliation:

1. University of California, San Francisco; San Francisco CA USA

2. University Hospital of Nantes; Nantes France

3. University Hôpital of Bicêtre; Le Kremlin-Bicêtre France

4. Medizinische Hochschule Hannover; Hannover Germany

5. University Hospital of Bellvitge; Barcelona Spain

6. Bristol-Myers Squibb; Lawrenceville NJ USA

7. Emory University Transplant Center; Atlanta GA USA

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14452/fullpdf

Reference17 articles.

1. Long-term renal allograft survival in the United States: A critical reappraisal;Lamb;Am J Transplant,2011

2. Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation;Krämer;Am J Transplant,2003

3. Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus;Ligtenberg;J Am Soc Nephrol,2001

4. The natural history of chronic allograft nephropathy;Nankivell;N Engl J Med,2003

5. Chronic renal failure after transplantation of a nonrenal organ;Ojo;N Engl J Med,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future;Kidney International Reports;2023-12

2. Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in France;Transplant International;2023-07-24

3. Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial;Transplantation Direct;2023-02-08

4. Selective CD28 blockade impacts T cell differentiation during homeostatic reconstitution following lymphodepletion;Frontiers in Immunology;2023-01-24

5. Belatacept in Kidney Transplantation: What Are the True Benefits? A Systematic Review;Frontiers in Medicine;2022-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3